Meta-analysis of efficacy and adverse events of erlotinib-based targeted therapies for advanced/metastatic non-small cell lung cancer | |
Li, Fei; Zhang, Shu-Hua; Pang, Li-Min | |
刊名 | ONCOTARGET |
2017 | |
卷号 | 8期号:49 |
关键词 | advanced/metastatic non-small-cell lung cancer targeted therapy efficacy adverse events randomized controlled trials |
ISSN号 | 1949-2553 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3514359 |
专题 | 吉林大学白求恩第三医院 |
推荐引用方式 GB/T 7714 | Li, Fei,Zhang, Shu-Hua,Pang, Li-Min. Meta-analysis of efficacy and adverse events of erlotinib-based targeted therapies for advanced/metastatic non-small cell lung cancer[J]. ONCOTARGET,2017,8(49). |
APA | Li, Fei,Zhang, Shu-Hua,&Pang, Li-Min.(2017).Meta-analysis of efficacy and adverse events of erlotinib-based targeted therapies for advanced/metastatic non-small cell lung cancer.ONCOTARGET,8(49). |
MLA | Li, Fei,et al."Meta-analysis of efficacy and adverse events of erlotinib-based targeted therapies for advanced/metastatic non-small cell lung cancer".ONCOTARGET 8.49(2017). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论